The FDA announced the approval of Ragwitek (Ambrosia artemisiifolia; Merck), the first sublingual allergen extract to treat short ragweed pollen induced allergic rhinitis, with or without conjunctivitis.
The FDA has approved a new indication for Arzerra (ofatumumab; GlaxoSmithKline) to use in combination with chlorambucil, for the treatment of previously untreated patients with chronic lymphocytic leukemia (CLL), for whom fludarabine-based therapy is considered inappropriate.
The Centers for Disease Control and Prevention (CDC) reports that although rates for some foodborne infections are on the decline, others remain stagnant or increased in 2013.
A telephone-based intervention improves mental health-related quality of life in cardiac patients with depression and/or anxiety disorders.
For patients with ischemic stroke, there is considerable variation in the rates of high-intensity computed tomography (CT) use.